|
Real-time Estimate
Cboe BZX
02:19:58 28/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 549.12 USD | +0.34% |
|
+1.69% | +21.19% |
| 13/08 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 11/08 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 563.12 | +2.89% | 25 | ||||||
| 1,315.04 | +10.56% | 29 | ||||||
| 272.5 | +0.93% | 22 | ||||||
| 276.59 | +5.21% | 29 | ||||||
| 370.31 | +0.54% | 18 | ||||||
| 154.32 | -2.25% | 21 | ||||||
| 212.58 | +27.85% | 22 | ||||||
| 388.48 | -11.78% | 29 | ||||||
| 310.82 | +1.92% | 23 | ||||||
| 157.41 | +6.29% | 27 | ||||||
| 28.61 | +1.08% | 26 | ||||||
| 66.21 | -2.02% | 24 | ||||||
| 94.28 | +20.42% | 23 | ||||||
| 21.69 | +14.18% | 20 | ||||||
| 9,350 | +32.61% | 15 | ||||||
| 6,515.81 | +11.19% | 16 | ||||||
| 57.39 | +16.86% | 18 | ||||||
| 71.74 | +53.48% | 17 | ||||||
| 41.4 | +9.18% | 10 | ||||||
| 4.214 | +12.89% | 17 | ||||||
| Average | 1,013.63 | +10.60% | 22 | ||||||
| Weighted average by Cap. | 701.42 | +6.61% | 24 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
